Enzon Pharmaceuticals (ENZN)
Add to Watchlists Create an Alert
3.16
+0.00 +0.00%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Enzon Pharmaceuticals Return on Assets:
0.25% for March 31, 2013Enzon Pharmaceuticals Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.25% |
| Dec. 31, 2012 | -0.93% |
| Sept. 30, 2012 | -0.80% |
| June 30, 2012 | -4.58% |
| March 31, 2012 | -5.97% |
| Dec. 31, 2011 | -5.14% |
| Sept. 30, 2011 | -5.55% |
| June 30, 2011 | -4.97% |
| March 31, 2011 | -4.40% |
| Dec. 31, 2010 | 36.84% |
| Sept. 30, 2010 | 41.09% |
| June 30, 2010 | 46.79% |
| March 31, 2010 | 52.05% |
| Dec. 31, 2009 | 0.20% |
| Sept. 30, 2009 | 0.23% |
| June 30, 2009 | -0.40% |
| March 31, 2009 | 0.55% |
| Dec. 31, 2008 | -0.74% |
| Sept. 30, 2008 | -0.52% |
| June 30, 2008 | 22.78% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
ENZN Return on Assets Benchmarks
| Companies | |
|---|---|
| Merck | 5.68% |
| Vertex Pharmaceuticals | -19.76% |
| AVEO Pharmaceuticals | -49.70% |
ENZN Return on Assets Rankings
| Overall |
57th percentile 3232 of 7600 |
| Sector |
64th percentile 231 of 653 in Healthcare |
| Industry |
85th percentile 34 of 238 in Biotechnology |
ENZN Return on Assets Range, Past 5 Years
| Minimum | -5.97% | Mar 2012 |
| Maximum | 52.05% | Mar 2010 |
| Average | 8.34% |
